Delivery Order SPE2DB24D2018-SPE2DB25FWRJ5

Award Date 10/16/24
Potential Completion Date 10/17/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D2018
    Indefinite Delivery Contract
  • SPE2DB24D2018-SPE2DB25FWRJ5
    Delivery Order

This federal contract award is for the delivery of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products. The contract, valued at $1,239.03, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price Delivery Order with a completion date of October 17, 2024. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen Drug Corp is a for-profit organization that maintains a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally.

Generated 1/15/25, 9:26 AM